Skip to main content

About CRUK Scotland Institute

Find out what we do, how we do it and why we do what we do.

A person walks across a city street at sunset, with tall buildings lining the road on both sides.

Life in Glasgow

Find out about living and working in Glasgow and Scotland.

Our Research

Explore the science at CRUK Scotland Institute. Our research groups, the people who lead them, and how we work.

Operations

The teams and services that keep the Institute running and support our research.

Partners

The networks and organisations we work with to accelerate cancer research.

Careers & Study

Jobs, studentships and opportunities for students at every stage at our world-renowned cancer research institute.

Studentships

PhD opportunities at the Institute

Studentship Vacancies

Open studentships to apply for

Internships

For undergraduate and masters students

Prof Crispin Miller

Computational Biology

As biology becomes increasingly data rich, the need for computational biology has grown rapidly. This leads to significant challenges, both in terms of providing the infrastructure to support the data management and analysis, and in terms of analysing the complex multimodal ‘deep phenotyping’ datasets we are generating.

A middle-aged man with short, light-coloured hair smiles warmly at the camera. He is wearing a black jumper over a white collared shirt, and the background is plain and light-coloured.
A blue pencil icon tilted diagonally, drawing a horizontal line on a plain light grey background.

Biography

click here to read
Blue icon of a document with horizontal lines representing text and a folded bottom right corner, on a light grey background.

Recent Publications

click here to read

Biography

Education and qualifications

  • 2000: PhD, Bioinformatics, The University of Manchester
  • 1996: BSc, Artificial Intelligence, The University of Manchester

Appointments

  • 2019–: Head of Bioinformatics, Cancer Research UK Scotland Institute
  • 2012–2018: Senior Group Leader, Cancer Research UK Manchester Institute
  • 2007–2012: Senior Staff Scientist, The Paterson Institute for Cancer Research, The University of Manchester
  • 2002–2007: Junior Group Leader, The Paterson Institute for Cancer Research, The University of Manchester
  • 2000–2002: MRC Fellowship, The University of Manchester

Funding

  • NC3R’s

Recent Publications

2026

White M., Mills M.L., Millett L.M., Gilroy K., Hong Y., Zeiger L.B., Simpson R.J., Corry S.M., Ligeza A., Lannagan T.R.M., Susanti S., Ridgway R.A., Yazgili A.S., Grzesiak L., Amirkhah R., Ford C.A., Vlahov N., Tovell H., Officer-Jones L., Ficken C., Pennie R., Najumudeen A.K., Raven A., Nasreddin N., Chauhan E., Papanastasiou A.S., Nixon C., Morrison V., Jackstadt R., Graham J.S., Miller C.J., Ross S.J., Barry S.T., Pavet V., Wilson R.H., Le Quesne J., Dunne P.D., Tejpar S., Leedham S., Campbell A.D., Sansom O.J. MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance (2026) Nature, 650 (8102), pp. 748 – 758 DOI: 10.1038/s41586-025-09916-w

Raven A., Gilroy K., Jin H., Waldron J.A., Leslie H., Munro J., Hall H., Ridgway R.A., Ford C.A., Gulhan D.C., Vlahov N., Mills M.L., Hartley A., Anderson E., Bryson S., Sphyris N., Müller M., May S., Cadden B., Nixon C., Waddell S.H., Guest R., Boulter L., Barker N., Clevers H., Zhu H., Ivaska J., Strathdee D., Miller C.J., Jamieson N.B., Bushell M., Park P.J., Bird T.G., Sansom O.J. Hepatic zonation determines tumorigenic potential of mutant β-catenin (2026) Nature, 649 (8097), pp. 739 – 748 DOI: 10.1038/s41586-025-09733-1

Kanellos G., Giacomelli C., Raven A., Vlahov N., Jin H., Herviou P., Malla S.B., Nasreddin N., Centeno P.P., Alexandrou C., Gilroy K., Baird R.L., Pennel K., Munro J., Waldron J.A., Hall H., Officer-Jones L., Bryson S., Strathdee D., Lilla S., Zanivan S., Morrison V., Nixon C., Ridgway R.A., Miller C., Knight J.R.P., Campbell A.D., Dunne P.D., Le Quesne J., Edwards J., Park P.J., Bushell M., Sansom O.J. Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation (2026) Nature Genetics, 58 (1), pp. 100 – 115 DOI: 10.1038/s41588-025-02408-7

Riggio A.I., Sweeney K., Shaw R., Lawlor A., Khan A., Ferrari N., Anand J., Galbraith L.C.A., Gilroy K., Bull C., Young A.L., Athineos D., Hall H., Ghaffar F., Hughes M., Mitchell C.A., Mitchell L., Nixon C., Adams P.D., Roberts E.W., Miller C.J., Dunne P.D., Campbell K.J., Cameron E.R., Blyth K. Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesis (2026) British Journal of Cancer, 135 (4), pp. 532 – 545 DOI: 10.1038/s41416-026-03439-5

Müller M., May S., Hall H., Kendall T.J., McGarry L., Blukacz L., Nuciforo S., Georgakopoulou A., Jamieson T., Phinichkusolchit N., Dhayade S., Suzuki T., Huguet-Pradell J., Powley I.R., Officer-Jones L., Pennie R.L., Esteban-Fabró R., Gris-Oliver A., Pinyol R., Skalka G.L., Leslie J., Hoare M., Sprangers J., Malviya G., Mackintosh A., Johnson E., McCain M., Halpin J., Kiourtis C., Nixon C., Clark G., Clark W., Shaw R., Hedley A., Drake T.M., Tan E.H., Neilson M., Murphy D.J., Lewis D.Y., Reeves H.L., Le Quesne J., Mann D.A., Carlin L.M., Blyth K., Llovet J.M., Heim M.H., Sansom O.J., Miller C.J., Bird T.G. Human-correlated genetic models identify precision therapy for liver cancer (2025) Nature, 639 (8055), pp. 754 – 764 DOI: 10.1038/s41586-025-08585-z

Liu D., Young F., Lamb K.D., Claudio Quiros A., Pancheva A., Miller C.J., Macdonald C., Robertson D.L., Yuan K. PLM-interact: extending protein language models to predict protein-protein interactions (2025) Nature Communications, 16 (1), art. no. 9012 DOI: 10.1038/s41467-025-64512-w

Malla S.B., Byrne R.M., Lafarge M.W., Corry S.M., Fisher N.C., Tsantoulis P.K., Mills M.L., Ridgway R.A., Lannagan T.R.M., Najumudeen A.K., Gilroy K.L., Amirkhah R., Maguire S.L., Mulholland E.J., Belnoue-Davis H.L., Grassi E., Viviani M., Rogan E., Redmond K.L., Sakhnevych S., McCooey A.J., Bull C., Hoey E., Sinevici N., Hall H., Ahmaderaghi B., Domingo E., Blake A., Richman S.D., Isella C., Miller C., Bertotti A., Trusolino L., Loughrey M.B., Kerr E.M., Tejpar S., Maughan T.S., Lawler M., Campbell A.D., Leedham S.J., Koelzer V.H., Sansom O.J., Dunne P.D. Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer (2024) Nature Genetics, 56 (3), pp. 458 – 472 DOI: 10.1038/s41588-024-01654-5

Wiesheu R., Edwards S.C., Hedley A., Hall H., Tosolini M., Fares da Silva M.G.F., Sumaria N., Castenmiller S.M., Wardak L., Optaczy Y., Lynn A., Hill D.G., Hayes A.J., Hay J., Kilbey A., Shaw R., Whyte D., Walsh P.J., Michie A.M., Graham G.J., Manoharan A., Halsey C., Blyth K., Wolkers M.C., Miller C., Pennington D.J., Jones G.W., Fournie J.-J., Bekiaris V., Coffelt S.B. IL-27 maintains cytotoxic Ly6C<sup>+</sup> γδ T cells that arise from immature precursors (2024) EMBO Journal, 43 (14), pp. 2878 – 2907 DOI: 10.1038/s44318-024-00133-1

Edwards S.C., Hedley A., Hoevenaar W.H.M., Wiesheu R., Glauner T., Kilbey A., Shaw R., Boufea K., Batada N., Hatano S., Yoshikai Y., Blyth K., Miller C., Kirschner K., Coffelt S.B. PD-1 and TIM-3 differentially regulate subsets of mouse IL-17A–producing γδ Tcells (2023) Journal of Experimental Medicine, 220 (2), art. no. e20211431 DOI: 10.1084/jem.20211431

Román-Fernández A., Mansour M.A., Kugeratski F.G., Anand J., Sandilands E., Galbraith L., Rakovic K., Freckmann E.C., Cumming E.M., Park J., Nikolatou K., Lilla S., Shaw R., Strachan D., Mason S., Patel R., McGarry L., Katoch A., Campbell K.J., Nixon C., Miller C.J., Leung H.Y., Le Quesne J., Norman J.C., Zanivan S., Blyth K., Bryant D.M. Spatial regulation of the glycocalyx component podocalyxin is a switch for prometastatic function (2023) Science Advances, 9 (5), art. no. eabq1858 DOI: 10.1126/sciadv.abq1858

Freckmann E.C., Sandilands E., Cumming E., Neilson M., Román-Fernández A., Nikolatou K., Nacke M., Lannagan O.J., Miller C.J., Bryant D.M. Traject3d allows label-free identification of distinct co-occurring phenotypes within 3D culture by live imaging (2022) Nature Communications, 13 (1), art. no. 5317 DOI: 10.1038/s41467-022-32958-x

Secret Link